Hostname: page-component-7c8c6479df-hgkh8 Total loading time: 0 Render date: 2024-03-26T18:27:22.840Z Has data issue: false hasContentIssue false

Psychosocial aspects of epilepsy: a wider approach

Published online by Cambridge University Press:  02 January 2018

Marco Mula
Affiliation:
Atkinson Morley Regional Neuroscience Centre, St George's University Hospitals NHS Foundation Trust, London, UK South West London and St George's Mental Health Trust, London, UK Institute of Medical and Biomedical Sciences, St George's University of London, London, UK
Josemir W. Sander*
Affiliation:
Department of Clinical and Experimental Epilepsy, NIHR UCL Hospitals Biomedical Research Centre, UCL Institute of Neurology, London, UK Epilepsy Society, Chalfont St Peter, UK Stichting Epilepsie Instellingen Nederland – SEIN, Heemstede, The Netherlands
*
Josemir W. Sander, National Hospital for Neurology and Neurosurgery, Box 29, Queen Square, London WC1N 3BG, UK. Email: l.sander@ucl.ac.uk
Rights & Permissions [Opens in a new window]

Summary

Epilepsy is one of the most serious neurological conditions and has an impact not only on the affected individual but also on the family and, indirectly, on the community. A global approach to the individual must take into account cognitive problems, psychiatric comorbidities and all psychosocial complications that often accompany epilepsy. We discuss psychosocial issues in epilepsy with special focus on the relationship between stigma and psychiatric comorbidities. Social barriers to optimal care and health outcomes for people with epilepsy result in huge disparities, and the public health system needs to invest in awareness programmes to increase public knowledge and reduce stigma in order to minimise such disparities.

Type
Review
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © The Royal College of Psychiatrists 2016

Epilepsy is among the most common serious neurological conditions with incidence rates, in high-income countries, ranging between 40 and 70 per 100 000 persons per year and generally higher in young children and in the elderly.Reference de Boer, Mula and Sander 1 Reference MacDonald, Cockerell, Sander and Shorvon 3 In resource-poor countries, the incidence is usually much higher, often above 120/100 000/year, and in high-income countries, poor people also seem to have a higher incidence.Reference Heaney, MacDonald, Everitt, Stevenson, Leonardi and Wilkinson 4 , Reference Ngugi, Kariuki, Bottomley, Kleinschmidt, Sander and Newton 5 Poor sanitation, inadequate health delivery systems and higher risk of brain infections and infestations may contribute to this.Reference de Boer, Mula and Sander 1 , Reference Sander and Bell 6 Prevalence studies have reported lifetime rates between 4 and 10/1000 in developed countries,Reference Duncan, Sander, Sisodiya and Walker 2 , Reference Forsgren, Beghi, Õun and Sillanpää 7 but data from resource-poor countries clearly suggest higher lifetime prevalence rates in the region of 23.2–32.1/1000Reference Bell, Neligan and Sander 8 up to 57/1000 in some selected cases in rural areas.Reference Sander and Shorvon 9

Many people with epilepsy live a normal life, but there is no doubt that the long-term prognosis of epilepsy is poor in many cases owing to increased morbidity and mortality.Reference Cockerell, Johnson, Sander and Shorvon 10 This can be because of physical causes (e.g. fractures, scalding, bruising) as well as comorbidity with other systemic diseasesReference Gaitatzis, Sisodiya and Sander 11 and increased psychosocial problems.Reference Gaitatzis, Trimble and Sander 12 People with epilepsy, particularly if chronic, have an increased risk of premature death.Reference Sander and Bell 6 , Reference Lhatoo, Johnson, Goodridge, MacDonald, Sander and Shorvon 13 , Reference Neligan, Bell, Johnson, Goodridge, Shorvon and Sander 14 Sudden unexpected death, trauma, suicide, pneumonia and status epilepticus have been identified as being more common in people with epilepsy.Reference Neligan, Bell, Johnson, Goodridge, Shorvon and Sander 14 , Reference Gaitatzis and Sander 15 Symptomatic epilepsy may reduce life expectancy by up to 18 years.Reference Gaitatzis, Sisodiya and Sander 11 Little is known about mortality in resource-poor countries as only a few adequate studies have been carried out to address this issue. Circumstantial evidence, however, suggests that the mortality rate is higher, helping to explain the discrepancy between the higher incidence and relatively low prevalence of active epilepsy in these countries.Reference de Boer, Mula and Sander 1

In May 2015, the World Health Assembly approved the WHO Resolution on the Global Burden of Epilepsy which provides a powerful tool to engage national governments into implementing effective actions to improve medical and social services for people with epilepsy, promote public awareness about epilepsy and allocate resources to epilepsy research.Reference Covanis, Guekht, Li, Secco, Shakir and Perucca 16 The resolution calls on the WHO Secretariat to continue to lead and coordinate support to member states in addressing the global burden of epilepsy so that people with epilepsy can receive timely treatment and can benefit from educational and occupational opportunities, free from stigma and discrimination.

The global perspective

Apart from good seizure control, numerous factors are involved in quality of life (QoL) of people with epilepsy. It is now well recognised that other factors, such as comorbid depression and adverse effects of medications, are far stronger predictors.Reference Birbeck, Hays, Cui and Vickrey 17 Even in those in whom remission is achievable, if this is at the expense of unacceptable side-effects, adherence and QoL remain poor.

Successful integration of people with epilepsy into society is another important goal in epilepsy care. Educational level, intellectual ability, psychological stability, family and social support, the ability to overcome stigma, transportation and mobility issues, and employment opportunities are important determinants of successful integration.Reference Hermann and Jacoby 18 The combination of these factors influences the life of people with epilepsy and what they consider meaningful.Reference Bautista, Shapovalov, Saada and Pizzi 19 For this reason, sport and leisure is becoming a new topic in epilepsy care and the International League against Epilepsy has a specific task force dedicated to Epilepsy and Sport and a report is now available.Reference Capovilla, Kaufman, Perucca, Moshé and Arida 20

The QoL of people with epilepsy also appears to be related to the level of social support they receive through the various societal structures, including emotional support, informational support, instrumental support, appraisal, social companionship and affectionate support.Reference Amir, Roziner, Knoll and Neufeld 21 Social support mechanisms help people to overcome many of the difficulties they encounter. Individuals with good social support usually have an increased sense of control over their lives, enabling them to have better coping mechanisms for handling adversities.Reference Amir, Roziner, Knoll and Neufeld 21 It is now clear that people with the highest level of social support have significantly lower reported stigma scores.Reference Dilorio, Osborne Shafer, Letz, Henry, Schomer and Yeager 22

Epilepsy is a condition still highly stigmatised, and stigma greatly affects the QoL of people with epilepsy, leading to increased anxiety and depression and poor adherence with medication.Reference Buck, Jacoby, Baker and Chadwick 23 Unfortunately, even today, stigma is present in both high-income and resource-poor countries.Reference de Boer, Mula and Sander 1 Stigma is not only responsible for poor QoL but also seems to play a role in mood and anxiety problems in both people with epilepsy and their caregivers. Perceived stigma is also responsible for increased rates of aggressive behaviour associated with depression and anxiety.Reference Seo, Kim and Park 24 In low- and middle-income countries, 20% of mothers of children with epilepsy feel stigmatised because of their child's neurological condition,Reference Elafros, Bowles, Atadzhanov, Mbewe, Haworth and Chomba 25 and the caregiver's perception of burden, together with the level of family function, are indirectly correlated with depressive symptoms in people with epilepsy via the mediating effect of caregiver depression.Reference Han, Kim and Lee 26 This is also present in high-income countries where social aspects of stigma are an important determinant of anxiety and depression.Reference Peterson, Walker and Shears 27

The US Centers for Disease Control and Prevention, Epilepsy Program, pointed out that one in five of those with epilepsy lives alone and less than one in four live in households with two adults and children. 28 Adults with epilepsy living alone may be at increased risk of injury associated with uncontrolled seizures, mental distress associated with social isolation, lower QoL and early mortality. Stigma affects attitude towards epilepsy and the more intimate life domains such as cohabitation and marriage. A number of studies have shown that people with epilepsy are less likely to be married and people suffering from the enacted stigma are significantly more likely to get divorced in comparison with others.Reference Friedrich, Taslak, Tomasovic and Bielen 29 Reference Tedrus, Fonseca and Pereira 31

In resource-poor countries, stigma directly affects access to healthcareReference Nehra, Singla, Bajpai, Malviya, Padma and Tripathi 32 , Reference Ali, Tomek and Lisk 33 and probably contributes to the discrepancy between the incidence and prevalence of epilepsy in lower-income regions of the world because diagnoses and clinical information are sometimes unreliable.Reference Mathern, Beninsig and Nehlig 34 As already stated, perceived stigma is a problem even in high-income countries and is probably a major determinant of poor adherence with medications.Reference Buck, Jacoby, Baker and Chadwick 23 The information–motivation–behavioural skills model is a useful framework for understanding the pathways linking perceived stigma and adherence in the population with epilepsy.Reference Chesaniuk, Choi, Wicks and Stadler 35 Living in a European country with better health system performance and higher health expenditure per capita does not necessarily lead to a reduction in perceived discrimination, unless the public health system invests in awareness programmes to increase public knowledge and reduce stigma.Reference Brigo, Igwe, Ausserer, Tezzon, Nardone and Otte 36 Low socio-economic status alone does not account for felt stigma, but depressive symptoms and poor social supports have the greatest impact on reported felt stigma in people with epilepsy.Reference Leaffer, Hesdorffer and Begley 37 Social barriers to optimal care and health outcomes for people with epilepsy result in huge disparities.Reference Szaflarski 38 Disparities area complex phenomenon that requires research and action. A systematic review has identified five domains of potential disparities in epilepsy care: access to medical and surgical treatment, outcomes following medical/surgical treatment, attitudes/knowledge about epilepsy, epidemiology and disability.Reference Burneo, Jette, Theodore, Begley, Parko and Thurman 39 Data on these domains were, however, limited. For example, a US national study has shown that White people and those privately insured were found to be more likely to have surgery compared with their respective minority and publicly insured counterparts.Reference Englot, Ouyang, Garcia, Barbaro and Chang 40 Furthermore, robust data collection and surveillance to identify points of intervention are urgently needed.

Cognitive problems

About 40% of people with epilepsy aged between 4 and 15 years have one or more additional neurological problems, the most common being intellectual disabilities, speech and language difficulties or other specific cognitive disabilities.Reference de Boer, Mula and Sander 1 In addition, intellectually disabled individuals are at an increased risk of behavioural problems.Reference Caplan and Austin 41 Those severely affected have higher healthcare needs than others because of the concomitant presence of other neurological disabilities (i.e. feeding and swallowing difficulties, inability to walk).Reference Kerr, Linehan, Thompson, Mula, Gil-Nagal and Zuberi 42

Epilepsy can have an impact on cognition in several ways. A degree of impairment in cognitive functions is frequently reported by people with epilepsy, ranging between 44% for difficulties in learning and psychomotor retardation to 59% for sleepiness or tiredness.Reference Meador 43 , Reference Mula and Trimble 44 In clinical practice, the majority of cognitive problems have multifactorial origins with many different variables often interlinked.Reference Mula and Trimble 44 Cognitive dysfunction in epilepsy is generally regarded as either trait dependent or state dependent.Reference Mula 45 Trait-dependent dysfunction is a stable condition owing to the underlying brain disorder, while state-dependent dysfunction is a potentially reversible condition owing to modifiable factors such as anti-epileptic drugs (AEDs), seizure frequency and pattern, and psychiatric comorbidities.

Whether poorly controlled epilepsy is associated with progressive cognitive deterioration is still controversial, and this has been demonstrated only for some specific syndromes: mesial temporal lobe epilepsy and epileptic encephalopathies.Reference Avanzini, Depaulis, Tassinari and De Curtis 46 Different epileptic encephalopathies seem to have specific patterns of cognitive deficits such as short-term visuospatial memory problems, executive dysfunction and frontal lobe dysfunction in Unverricht–Lundborg syndrome,Reference Giovagnoli, Canafoglia, Reati, Raviglione and Franceschetti 47 , Reference Ferlazzo, Gagliano, Calarese, Magaudda, Striano and Cortese 48 language dysfunction in Landau–Kleffner syndromeReference Billard, Fluss and Pinton 49 and poor language acquisition and visuospatial defects in DravetReference Wolff, Cassé-Perrot and Dravet 50 and Rett syndrome.Reference Siegel and Smith 51 Finally, epileptic encephalopathies associated with frequent and uncontrolled seizures during sleep are characterised by memory and language problems.Reference Tassinari, Cantalupo, Rios-Pohl, Giustina and Rubboli 52

Cognitive problems are important in the long-term management of people with epilepsy, having an impact on QoL and everyday functioning.Reference Reilly, Atkinson, Das, Chin, Aylett and Burch 53 , Reference Mula and Cock 54 A US study showed that a self-management intervention targeting cognitive dysfunction can significantly improve not only cognitive performance but also QoL.Reference Caller, Ferguson, Roth, Secore, Alexandre and Zhao 55 Access to investigations, appropriate testing and review are important parts of the management.

Epilepsy has also a clear impact on relatives and carers of people with epilepsy, especially when seizures start during childhood. A Swedish study showed that mothers and fathers of children with drug-resistant epilepsy have poorer QoL compared with population norms, and symptoms of anxiety seem to be common especially among mothers.Reference Reilly, Taft, Nelander, Malmgren and Olsson 56

Psychiatric problems

Psychiatric disorders are relatively frequent comorbidities in epilepsy, with a lifetime history identified in one in three people with epilepsy.Reference Lin, Mula and Hermann 57 Mood and anxiety disorders are the most frequently reportedReference Tellez-Zenteno, Patten, Jette, Williams and Wiebe 58 for both biological and psychosocial reasons. The burden of stigma, social limitations and discrimination in epilepsy lead to demoralisation and poor self-esteem, but the pathophysiology of epilepsy per se is interlinked with mood problems as demonstrated by neuroanatomical and neurochemical principles. The involvement of the temporal lobesReference Quiske, Helmstaedter, Lux and Elger 59 and the psychotropic effects of AEDsReference Perucca and Mula 60 seem to be relevant contributors to the increased rates of psychiatric problems in epilepsy but much remains unknown regarding the role of shared versus syndrome-specific variables and the role of cortico-subcortical networks. In addition, a number of epidemiological studies have suggested that the relationship between epilepsy and psychiatric problems is not necessarily unilateral but rather bidirectional and some people may present with a psychiatric disorder before the emergence of seizures.Reference Hesdorffer, Hauser, Annegers and Cascino 61 Reference Hesdorffer, Ishihara, Mynepalli, Webb, Weil and Hauser 63

Depression is an important predictor of poor QoL,Reference Boylan, Flint, Labovitz, Jackson, Starner and Devinsky 64 seizure severity,Reference Cramer, Blum, Reed and Fanning 65 drug-resistanceReference Hitiris, Mohanraj, Norrie, Sills and Brodie 66 and a poor outcome after epilepsy surgery.Reference Kanner 67 Nonetheless, mood disorders are still under-recognised, under-treated and sometimes fully ignored, unless they are severe enough to reach medical attention. A number of reasons can explain the diagnostic delay and inaccuracy, including individuals’ reluctance spontaneously to volunteer information about existing psychiatric problems, a paucity (or total lack) of training for the treating neurologist to recognise psychiatric symptoms and a lack of time in very busy clinics to screen for them. The result is that epilepsy is often complicated and burdened by psychiatric disturbances or behavioural problems that are not adequately addressed or managed.

Suicide is a severe complication of untreated and undiagnosed depression. In the context of epilepsy, suicide is gaining increasing attention, and it has been recently reinvigorated by the Food and Drug Administration alert on a supposedly increased risk of suicidal ideation and behaviour in people taking AEDs.Reference Mula and Sander 68 In the general population, suicide is the 11th cause of death and the second in the age group between 25 and 34 years.Reference Gelder 69 It is now evident thatthe overall risk of death by suicide is about three times higher in people with epilepsy than in the general population.Reference Harris and Barraclough 70 Reference Christensen, Vestergaard, Mortensen, Sidenius and Agerbo 72 Several studies have attempted to identify reasons for this increased risk. In the general population, about 90% of people who die by suicide have at least one psychiatric disorder at the time.Reference Cavanagh, Carson, Sharpe and Lawrie 73 Epilepsy is burdened by psychiatric comorbidities, but it is unlikely that such a problem is the only responsible element. A Danish study reported that the rate ratio of suicide in people with epilepsy is still doubled even after excluding people with psychiatric comorbidity and adjusting for various factors.Reference Christensen, Vestergaard, Mortensen, Sidenius and Agerbo 72 Some have suggested a link with temporal lobe epilepsy,Reference Harris and Barraclough 70 but a recent study, using retrospective and prospective methods, found no epilepsy-related factors.Reference Hara, Akanuma, Adachi, Hara and Koutroumanidis 74 The issue of epilepsy and suicide is still far from being elucidated, but it is likely to be multifactorial with biological, constitutional and psychosocial variables being implicated. It seems evident that suicide prevention is another relevant issue in epilepsy care deserving further clinical attention.

People with epilepsy historically have been considered to have an increased risk of developing psychotic disorders. Epidemiological evidence suggests that the incidence of non-organic, non-affective psychoses, including schizophrenia and schizophrenia spectrum disorders, is generally over-represented among people with epilepsy compared with the general population or other chronic medical conditions.Reference Bredkjaer, Mortensen and Parnas 75 A family history of psychoses and a family history of epilepsy were significant risk factors for psychosis suggesting strong neurobiological underpinnings.Reference Qin, Xu, Laursen, Vestergaard and Mortensen 76 In general terms, psychoses represent a rare but serious complication of epilepsy. Close attention to the relationship between psychotic symptoms and seizure pattern is crucial to identify seizure-based phenomena such as postictal psychoses or the forced normalisation phenomenon.Reference Mula 77 Chronic interictal schizophrenia-like psychoses can be occasionally seen and deserve careful consideration.

The increasing attention to the psychiatric comorbidities of epilepsy brings to light the issue of double stigma. No studies investigated the relative contribution of the two conditions, epilepsy and mental health issues, but the problem of double stigma is well-known in other medical conditions such as obesity and mental healthReference Mizock 78 or the comorbidity between HIV and tuberculosisReference Daftary 79 in low-income countries. Double stigma means double challenge and for this reason it becomes even more important to invest energies and resources.

Epilepsy is one of the most common neurological conditions, and it has an impact not only on the individual with epilepsy but also on the family and, indirectly, on the community. A global approach to the individual must take into account the cognitive problems and psychiatric comorbidities that often accompany epilepsy. The burden of epilepsy concerns not only the physical hazards of epilepsy but also the psychosocial consequences involved, such as the negative attitudes of people towards the patients, manifested as social stigma, social isolation and lack of support. Social barriers to optimal care and health outcomes for people with epilepsy result in huge disparities, and the public health system should invest in awareness programmes to increase public knowledge and reduce stigma in order to minimise such disparities.

Acknowledgements

JWS. is based at UCL Hospitals Biomedical Research Centre, which receives a portion of funding from the UK Department of Health's National Institute for Health Research Biomedical Research Centre's funding scheme.

Footnotes

Declarations of interest

J.W.S. receives research support from the Dr Marvin Weil Epilepsy Research Fund, Eisai, GlaxoSmithKline, the World Health Organization and the EU's FP7 programme, and has been consulted by, and has received fees for lectures from, GlaxoSmithKline, Eisai, Lundbeck, Teva and UCB.

References

1 de Boer, HM, Mula, M, Sander, JW. The global burden and stigma of epilepsy. Epilepsy Behav 2008; 12: 540–6.Google Scholar
2 Duncan, JS, Sander, JW, Sisodiya, SM, Walker, MC. Adult epilepsy. Lancet 2006; 367: 1087–100.CrossRefGoogle ScholarPubMed
3 MacDonald, BK, Cockerell, OC, Sander, JW, Shorvon, SD. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 2000; 123: 665–76.CrossRefGoogle Scholar
4 Heaney, DC, MacDonald, BK, Everitt, A, Stevenson, S, Leonardi, GS, Wilkinson, P, et al. Socioeconomic variation in incidence of epilepsy: prospective community based study in south east England. BMJ 2002; 325: 1013–6.Google Scholar
5 Ngugi, AK, Kariuki, SM, Bottomley, C, Kleinschmidt, I, Sander, JW, Newton, CR. Incidence of epilepsy: a systematic review and meta-analysis. Neurology 2011; 77: 1005–12.Google Scholar
6 Sander, JW, Bell, GS. Reducing mortality: an important aim of epilepsy management. J Neurol Neurosurg Psychiatry 2004; 75: 349–51.Google Scholar
7 Forsgren, L, Beghi, E, Õun, A, Sillanpää, M. The epidemiology of epilepsy in Europe – A systematic review. Eur J Neurol 2005; 12: 245–53.Google Scholar
8 Bell, GS, Neligan, A, Sander, JW. An unknown quantity – the worldwide prevalence of epilepsy. Epilepsia 2014; 55: 958–62.CrossRefGoogle ScholarPubMed
9 Sander, JW, Shorvon, SD. Epidemiology of the epilepsies. J Neurol Neurosurg Psychiatry 1996; 61: 433–43.CrossRefGoogle ScholarPubMed
10 Cockerell, OC, Johnson, AL, Sander, JW, Shorvon, SD. Prognosis of epilepsy: a review and further analysis of the first nine years of the British National General Practice Study of Epilepsy, a prospective population-based study. Epilepsia 1997; 38: 3146.Google Scholar
11 Gaitatzis, A, Sisodiya, SM, Sander, JW. The somatic comorbidity of epilepsy: a weighty but often unrecognized burden. Epilepsia 2012; 53: 1282–93.Google Scholar
12 Gaitatzis, A, Trimble, MR, Sander, JW. The psychiatric comorbidity of epilepsy. Acta Neurol Scand 2004; 110: 207–20.Google Scholar
13 Lhatoo, SD, Johnson, AL, Goodridge, DM, MacDonald, BK, Sander, JW, Shorvon, SD. Mortality in epilepsy in the first 11 to 14 years after diagnosis: multivariate analysis of a long-term, prospective, population-based cohort. Ann Neurol 2001; 49: 336–44.Google Scholar
14 Neligan, A, Bell, GS, Johnson, AL, Goodridge, DM, Shorvon, SD, Sander, JW. The long-term risk of premature mortality in people with epilepsy. Brain 2011; 134: 388–95.Google Scholar
15 Gaitatzis, A, Sander, JW. The mortality of epilepsy revisited. Epileptic Disord 2004; 6: 313.Google Scholar
16 Covanis, A, Guekht, A, Li, S, Secco, M, Shakir, R, Perucca, E. From global campaign to global commitment: The World Health Assembly's Resolution on epilepsy. Epilepsia 2015; 56: 1651–7.Google Scholar
17 Birbeck, GL, Hays, RD, Cui, X, Vickrey, BG. Seizure reduction and quality of life improvements in people with epilepsy. Epilepsia 2002; 43: 535–8.Google Scholar
18 Hermann, B, Jacoby, A. The psychosocial impact of epilepsy in adults. Epilepsy Behav 2009; 15(suppl 1): S2630.CrossRefGoogle ScholarPubMed
19 Bautista, RED, Shapovalov, D, Saada, F, Pizzi, MA. The societal integration of individuals with epilepsy: perspectives for the 21st century. Epilepsy Behav 2014; 35C: 42–9.Google Scholar
20 Capovilla, G, Kaufman, KR, Perucca, E, Moshé, SL, Arida, RM. Epilepsy, seizures, physical exercise, and sports: a report from the ILAE Task Force on Sports and Epilepsy. Epilepsia 2016; 57: 612.Google Scholar
21 Amir, M, Roziner, I, Knoll, A, Neufeld, MY. Self-efficacy and social support as mediators in the relation between disease severity and quality of life in patients with epilepsy. Epilepsia 1999; 40: 216–24.Google Scholar
22 Dilorio, C, Osborne Shafer, P, Letz, R, Henry, T, Schomer, DL, Yeager, K, et al. The association of stigma with self-management and perceptions of health care among adults with epilepsy. Epilepsy Behav 2003; 4: 259–67.Google Scholar
23 Buck, D, Jacoby, A, Baker, GA, Chadwick, DW. Factors influencing compliance with antiepileptic drug regimes. Seizure 1997; 6: 8793.Google Scholar
24 Seo, J-G, Kim, J-M, Park, S-P. Perceived stigma is a critical factor for interictal aggression in people with epilepsy. Seizure 2015; 26: 2631.Google Scholar
25 Elafros, MA, Bowles, RP, Atadzhanov, M, Mbewe, E, Haworth, A, Chomba, E, et al. Reexamining epilepsy-associated stigma: validation of the Stigma Scale of Epilepsy in Zambia. Qual Life Res 2015; 24: 1483–9.Google Scholar
26 Han, SH, Kim, B, Lee, SA, Korean QoL in Epilepsy Study Group. Contribution of the family environment to depression in Korean adults with epilepsy. Seizure 2015; 25: 2631.Google Scholar
27 Peterson, CL, Walker, C, Shears, G. The social context of anxiety and depression: exploring the role of anxiety and depression in the lives of Australian adults with epilepsy. Epilepsy Behav 2014; 34: 2933.CrossRefGoogle ScholarPubMed
28 Program UCFDCAPE. Nearly one in five adults with active epilepsy lives alone based on findings from the 2010 and 2013 US National Health Interview Surveys. US Centers for Disease Control and Prevention, Epilepsy PProgram. Epilepsy Behav 2015; 51: 259–60.Google Scholar
29 Friedrich, L, Taslak, M, Tomasovic, S, Bielen, I. How does the label ‘epileptic’ influence attitudes toward epilepsy? Seizure 2015; 33: 54–9.Google Scholar
30 Riasi, H, Rajabpour Sanati, A, Ghaemi, K. The stigma of epilepsy and its effects on marital status. Springerplus 2014; 3: 762.Google Scholar
31 Tedrus, GMAS, Fonseca, LC, Pereira, RB. Marital status of patients with epilepsy: factors and quality of life. Seizure 2015; 27: 6670.Google Scholar
32 Nehra, A, Singla, S, Bajpai, S, Malviya, S, Padma, V, Tripathi, M. Inverse relationship between stigma and quality of life in India: is epilepsy a disabling neurological condition? Epilepsy Behav 2014; 39C: 116–25.Google Scholar
33 Ali, DB, Tomek, M, Lisk, DR. The effects of epilepsy on child education in Sierra Leone. Epilepsy Behav 2014; 37C: 236–40.Google Scholar
34 Mathern, GW, Beninsig, L, Nehlig, A. Reasons for discrepancy between incidence and prevalence of epilepsy in lower income countries: Epilepsia's survey results. Epilepsia 2015; 56: 163–5.Google Scholar
35 Chesaniuk, M, Choi, H, Wicks, P, Stadler, G. Perceived stigma and adherence in epilepsy: evidence for a link and mediating processes. Epilepsy Behav 2014; 41: 227–31.Google Scholar
36 Brigo, F, Igwe, SC, Ausserer, H, Tezzon, F, Nardone, R, Otte, WM. Epilepsy-related stigma in European people with epilepsy: correlations with health system performance and overall quality of life. Epilepsy Behav 2015; 42C: 1821.Google Scholar
37 Leaffer, EB, Hesdorffer, DC, Begley, C. Psychosocial and sociodemographic associates of felt stigma in epilepsy. Epilepsy Behav 2014; 37C: 104–9.Google Scholar
38 Szaflarski, M. Social determinants of health in epilepsy. Epilepsy Behav 2014; 41: 283–9.Google Scholar
39 Burneo, JG, Jette, N, Theodore, W, Begley, C, Parko, K, Thurman, DJ, et al. Disparities in epilepsy: report of a systematic review by the North American Commission of the international league against epilepsy. Epilepsia 2009; 50: 2285–95.Google Scholar
40 Englot, DJ, Ouyang, D, Garcia, PA, Barbaro, NM, Chang, EF. Epilepsy surgery trends in the United States, 1990–2008. Neurology 2012; 78: 1200–6.Google Scholar
41 Caplan, R, Austin, JK. Behavioral aspects of epilepsy in children with mental retardation. Ment Retard Dev Disabil Res Rev 2000; 6: 293–9.Google Scholar
42 Kerr, M, Linehan, C, Thompson, R, Mula, M, Gil-Nagal, A, Zuberi, SM, et al. A White Paper on the medical and social needs of people with epilepsy and intellectual disability: the Task Force on Intellectual Disabilities and Epilepsy of the International League against Epilepsy. Epilepsia 2014; 55: 1902–6.Google Scholar
43 Meador, KJ. Cognitive and memory effects of the new antiepileptic drugs. Epilepsy Res 2006; 68: 63–7.Google Scholar
44 Mula, M, Trimble, MR. Antiepileptic drug-induced cognitive adverse effects: potential mechanisms and contributing factors. CNS Drugs 2009; 23: 121–37.Google Scholar
45 Mula, M. Cognitive dysfunction in patients with epilepsy: focus on clinical variables. Future Neurol 2015; 10: 41–8.Google Scholar
46 Avanzini, G, Depaulis, A, Tassinari, A, De Curtis, M. Do seizures and epileptic activity worsen epilepsy and deteriorate cognitive function? Epilepsia 2013; 54(suppl 8): 1421.Google Scholar
47 Giovagnoli, AR, Canafoglia, L, Reati, F, Raviglione, F, Franceschetti, S. The neuropsychological pattern of Unverricht-Lundborg disease. Epilepsy Res 2009; 84: 217–23.Google Scholar
48 Ferlazzo, E, Gagliano, A, Calarese, T, Magaudda, A, Striano, P, Cortese, L, et al. Neuropsychological findings in patients with Unverricht-Lundborg disease. Epilepsy Behav 2009; 14: 545–9.Google Scholar
49 Billard, C, Fluss, J, Pinton, F. Specific language impairment versus Landau-Kleffner syndrome. Epilepsia 2009; 50: 21–4.Google Scholar
50 Wolff, M, Cassé-Perrot, C, Dravet, C. Severe myoclonic epilepsy of infants (Dravet syndrome): natural history and neuropsychological findings. Epilepsia 2006; 47: 45–8.Google Scholar
51 Siegel, MS, Smith, WE. Psychiatric features in children with genetic syndromes: toward functional phenotypes. Pediatr Clin North Am 2011; 58: 833–64.Google Scholar
52 Tassinari, CA, Cantalupo, G, Rios-Pohl, L, Giustina, ED, Rubboli, G. Encephalopathy with status epilepticus during slow sleep: ‘the Penelope syndrome’. Epilepsia 2009; 50(suppl 7): 48.CrossRefGoogle ScholarPubMed
53 Reilly, C, Atkinson, P, Das, KB, Chin, RFM, Aylett, SE, Burch, V, et al. Factors associated with quality of life in active childhood epilepsy: a population-based study. Eur J Paediatr Neurol 2015; 19: 308–13.Google Scholar
54 Mula, M, Cock, HR. More than seizures: improving the lives of people with refractory epilepsy. Eur J Neurol 2015; 22: 2430.Google Scholar
55 Caller, TA, Ferguson, RJ, Roth, RM, Secore, KL, Alexandre, FP, Zhao, W, et al. A cognitive behavioral intervention (HOBSCOTCH) improves quality of life and attention in epilepsy. Epilepsy Behav 2016; 57: 111–7.Google Scholar
56 Reilly, C, Taft, C, Nelander, M, Malmgren, K, Olsson, I. Health-related quality of life and emotional well-being in parents of children with epilepsy referred for presurgical evaluation in Sweden. Epilepsy Behav 2015; 53: 10–4.CrossRefGoogle ScholarPubMed
57 Lin, JJ, Mula, M, Hermann, BP. Uncovering the neurobehavioural comorbidities of epilepsy over the lifespan. Lancet 2012; 380: 1180–92.Google Scholar
58 Tellez-Zenteno, JF, Patten, SB, Jette, N, Williams, J, Wiebe, S. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia 2007; 48: 2336–44.Google Scholar
59 Quiske, A, Helmstaedter, C, Lux, S, Elger, CE. Depression in patients with temporal lobe epilepsy is related to mesial temporal sclerosis. Epilepsy Res 2000; 39: 121–5.Google Scholar
60 Perucca, P, Mula, M. Antiepileptic drug effects on mood and behavior: molecular targets. Epilepsy Behav 2013; 26: 440–9.Google Scholar
61 Hesdorffer, DC, Hauser, WA, Annegers, JF, Cascino, G. Major depression is a risk factor for seizures in older adults. Ann Neurol 2000; 47: 246–9.Google Scholar
62 Hesdorffer, DC, Hauser, WA, Olafsson, E, Ludvigsson, P, Kjartansson, O. Depression and suicide attempt as risk factors for incident unprovoked seizures. Ann Neurol 2006; 59: 3541.Google Scholar
63 Hesdorffer, DC, Ishihara, L, Mynepalli, L, Webb, DJ, Weil, J, Hauser, WA. Epilepsy, suicidality, and psychiatric disorders: a bidirectional association. Ann Neurol 2012; 72: 184–91.Google Scholar
64 Boylan, LS, Flint, LA, Labovitz, DL, Jackson, SC, Starner, K, Devinsky, O. Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy. Neurology 2004; 62: 258–61.CrossRefGoogle Scholar
65 Cramer, JA, Blum, D, Reed, M, Fanning, K. The influence of comorbid depression on seizure severity. Epilepsia 2003; 44: 1578–84.Google Scholar
66 Hitiris, N, Mohanraj, R, Norrie, J, Sills, GJ, Brodie, MJ. Predictors of pharmacoresistant epilepsy. Epilepsy Res 2007; 75: 192–6.Google Scholar
67 Kanner, AM. Depression in epilepsy: a complex relation with unexpected consequences. Curr Opin Neurol 2008; 21: 190–4.Google Scholar
68 Mula, M, Sander, JW. Suicide and epilepsy: do antiepileptic drugs increase the risk? Expert Opin Drug Saf 2015; 14: 553–8.Google Scholar
69 Gelder, MG. New Oxford Textbook of Psychiatry. 2nd edn. Oxford University Press, 2009.Google Scholar
70 Harris, EC, Barraclough, B. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry 1997; 170: 205–28.Google Scholar
71 Bell, GS, Gaitatzis, A, Bell, CL, Johnson, AL, Sander, JW. Suicide in people with epilepsy: how great is the risk? Epilepsia 2009; 50: 1933–42.Google Scholar
72 Christensen, J, Vestergaard, M, Mortensen, PB, Sidenius, P, Agerbo, E. Epilepsy and risk of suicide: a population-based case-control study. Lancet Neurol 2007; 6: 693–8.Google Scholar
73 Cavanagh, JT, Carson, AJ, Sharpe, M, Lawrie, SM. Psychological autopsy studies of suicide: a systematic review. Psychol Med 2003; 33: 395405.Google Scholar
74 Hara, E, Akanuma, N, Adachi, N, Hara, K, Koutroumanidis, M. Suicide attempts in adult patients with idiopathic generalized epilepsy. Psychiatry Clin Neurosci 2009; 63: 225–9.Google Scholar
75 Bredkjaer, SR, Mortensen, PB, Parnas, J. Epilepsy and non-organic non-affective psychosis: national epidemiologic study. Br J Psychiatry 1998; 172: 235–8.CrossRefGoogle ScholarPubMed
76 Qin, P, Xu, H, Laursen, TM, Vestergaard, M, Mortensen, PB. Risk for schizophrenia and schizophrenia-like psychosis among patients with epilepsy: population based cohort study. BMJ 2005; 331: 23.Google Scholar
77 Mula, M. The Landolt's phenomenon: an update. Epileptologia 2010; 18: 3944.Google Scholar
78 Mizock, L. The double stigma of obesity and serious mental illnesses: promoting health and recovery. Stigma Heal 2015; 1: 8691.Google Scholar
79 Daftary, A. HIV and tuberculosis: the construction and management of double stigma. Soc Sci Med 2012; 74: 1512–9.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.